Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: Evidence for nuclear localization

被引:84
|
作者
Shimojo, M
Ricketts, ML
Petrelli, MD
Moradi, P
Johnson, GD
Bradwell, AR
Hewison, M
Howie, AJ
Stewart, PM
机构
[1] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[2] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT PATHOL, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
关键词
D O I
10.1210/en.138.3.1305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from patients with the hypertensive syndrome apparent mineralocorticoid excess, recently explained on the basis of mutations in the human 11 beta HSD2 gene, suggest that it is the 11 beta HSD2 isoform that serves a vital role in dictating specificity upon the mineralocorticoid receptor (MR). We have raised a novel antibody in sheep against human 11 beta HSD2 using synthetic multiantigenic peptides and have examined the localization and subcellular distribution of 11 beta HSD2 in mineralocorticoid target tissues. The immunopurified antibody recognized a single band of approximately 44 kDa in placenta, trophoblast, and distal colon. In kidney tissue, two bands of approximately 44 and 48 kDa were consistently observed. No signal was seen in decidua, adrenal, or liver. Immunoperoxidase studies on the mineralocorticoid target tissues, kidney, colon, and parotid gland indicated positive staining in epithelial cells known to express the MR: respectively, renal collecting ducts, surface and crypt colonic epithelial cells, and parotid duct epithelial cells. No staining was seen in these tissues in other sites. The intracellular localization of 11 beta HSD2 in kidney and colon epithelial cells was addressed using confocal laser microscopy. Parallel measurements of 11 beta HSD2 and nuclear propidium iodide fluorescence on sections scanned through an optical section of approximately 0.1 mu m indicated significant 11 beta HSD2 immunofluorescence in the nucleus. In human kidney, colon, and salivary gland, 11 beta HSD2 protects the MR from glucocorticoid excess in an autocrine fashion. Furthermore, within these tissues, 11 beta HSD2, which had been considered to be a microsomal enzyme, is also found in the nucleus, suggesting that the interaction between the MR and aldosterone or cortisol is in part a nuclear event.
引用
收藏
页码:1305 / 1311
页数:7
相关论文
共 50 条
  • [1] Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues
    Smith, RE
    Maguire, JA
    SteinOakley, AN
    Sasano, H
    Takahashi, KI
    Fukushima, K
    Krozowski, ZS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09): : 3244 - 3248
  • [2] Differential expression of nuclear 11 beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues
    Petrelli, MD
    LimTio, SS
    Condon, J
    Hewison, M
    Stewart, PM
    ENDOCRINOLOGY, 1997, 138 (07) : 3077 - 3080
  • [3] Localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat tissues: In situ studies
    Roland, BL
    Funder, JW
    ENDOCRINOLOGY, 1996, 137 (03) : 1123 - 1128
  • [4] Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders
    Sasano, H
    Frost, AR
    Saitoh, R
    Matsunaga, G
    Nagura, H
    Krozowski, ZS
    Silverberg, SG
    ANTICANCER RESEARCH, 1997, 17 (3C) : 2001 - 2007
  • [5] Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia
    Hirasawa, G
    Sasano, H
    Takahashi, KI
    Fukushima, K
    Suzuki, T
    Hiwatashi, N
    Toyota, T
    Krozowski, ZS
    Nagura, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11): : 3859 - 3863
  • [6] The 11 beta-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - Role of type-1 11 beta-hydroxysteroid dehydrogenase in detoxification processes
    Maser, E
    Oppermann, UCT
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (02): : 365 - 369
  • [7] 11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
    White, PC
    Mune, T
    Agarwal, AK
    ENDOCRINE REVIEWS, 1997, 18 (01) : 135 - 156
  • [8] The 11 beta-hydroxysteroid dehydrogenase system, a determinant of glucocorticoid and mineralocorticoid action - Medical and physiological aspects of the 11 beta-hydroxysteroid dehydrogenase system
    Seckl, JR
    Chapman, KE
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (02): : 361 - 364
  • [9] Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme
    Smith, RE
    Little, PJ
    Maguire, JA
    SteinOakley, AN
    Krozowski, ZS
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (6-7) : 549 - 551
  • [10] Localization of 11 beta-hydroxysteroid dehydrogenase: Specific protector of the mineralocorticoid receptor in mammalian olfactory mucosa
    Kern, RC
    Pitovski, DZ
    ACTA OTO-LARYNGOLOGICA, 1997, 117 (05) : 738 - 743